Search

9 May 2022: Hybridoma cell line producing SIg 743 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR CT-1 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 83-7 antibodies raised against the human insulin receptor, which are mouse monoclonal antibodies of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR CT-3 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 47-9 antibodies raised against the alpha subunit of the human insulin receptor,which are monoclonals of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-45 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-43 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-42 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 83-14 antibodies against the alpha subunit of the human insulin receptor, which are mouse monoclonals of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-44 antibodies raised against beta subunit of the human insulin receptor which are mouse monoclonals of IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 83-12 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 25-49 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-40 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-34 antibodies raised against the extracellular domain of the human insulin receptor which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 83-22 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing YTS 154.7.7.10 antibodies raised against mouse Thy-1 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 18-146 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing YTS 121.5.2 antibodies raised against mouse CD5 (lyt-1) which are rat monoclonal antibodies of the IgG2b isotype.